VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

Cytosorbents Corporation (CTSO) Total Return Calculator with Dividends Reinvested

Cytosorbents Corporation

Popular:

The total return for Cytosorbents Corporation (CTSO) stock is -30.97% over the past 12 months. So far it's down 7.09% this year. The 5-year total return is -92.75%, meaning $10,000 invested in CTSO stock 5 years ago would be worth $725 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in CTSO 1 year ago, it would be worth $7,006 today — you'd have lost $2,994.

With Dividends Reinvested$7,006-29.94%

Price Only (No DRIP)$7,006-29.94%

Period2025-05-08 → 2026-05-07

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in CTSO

1Y$6,903-$3,097 (-31.0%)-31.0% CAGR

3Y$2,154-$7,846 (-78.5%)-40.1% CAGR

5Y$725-$9,275 (-92.8%)-40.8% CAGR

10Y$1,364-$8,636 (-86.4%)-18.1% CAGR

15Y$1,189-$8,811 (-88.1%)-13.2% CAGR

20Y$80-$9,920 (-99.2%)-21.5% CAGR

30Y$80-$9,920 (-99.2%)-14.9% CAGR

Cytosorbents Corporation did not pay dividends during this period. Total return = price return.

Loading CTSO total return...

As of 2026-05-08

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	-7.09%	—	-7.09%	—	$9,291
1Y	-30.97%	-30.97%	-30.97%	—	$6,903
3Y	-78.46%	-40.06%	-78.46%	—	$2,154
5Y	-92.75%	-40.84%	-92.75%	—	$725
10Y	-86.36%	-18.07%	-86.36%	—	$1,364
15Y	-88.11%	-13.23%	-88.11%	—	$1,189
20Y	-99.20%	-21.45%	-99.20%	—	$80
30Y	-99.20%	-14.87%	-99.20%	—	$80

Risk & Highlights

Best Year+213.39%2014

Worst Year-87.43%2007

Max Drawdown-57.57%2025-07-01 → 2026-04-01

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	+14.71%	+14.71%	—	+0.41%	+14.3pp
2025	-30.54%	-30.54%	—	+16.64%	-47.2pp
2024	-14.95%	-14.95%	—	+24.00%	-39.0pp
2023	-39.01%	-39.01%	—	+24.81%	-63.8pp
2022	-63.36%	-63.36%	—	-19.95%	-43.4pp

CTSO underperformed the S&P 500 by 61.35pp over the past year (-30.97% vs +30.37%).

Loading summary...

CTSO Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
CTSOCytosorbents Corporation	$38M	-0.1%	-7.1%	-31.0%	—	-78.5%	-92.8%	-86.4%
NVCRNovoCure Limited	$1.9B	+62.6%	+28.3%	+1.1%	—	-75.7%	-91.3%	+30.3%
MASIMasimo Corporation	$9.3B	-0.1%	+40.1%	+18.9%	—	-4.9%	-20.4%	+282.9%
ICUIICU Medical, Inc.	$3.1B	+2.7%	-11.2%	-8.5%	—	-33.1%	-38.4%	+19.0%
LMATLeMaitre Vascular, Inc.	$2.5B	-2.2%	+34.9%	+33.3%	+1.0pp	+65.2%	+118.2%	+608.6%
ATRCAtriCure, Inc.	$1.4B	-3.8%	-29.2%	-8.3%	—	-41.8%	-64.2%	+95.1%
BAXBaxter International Inc.	$9.0B	+5.4%	-10.2%	-41.8%	+1.2pp	-56.3%	-74.3%	-42.4%
KRMDKORU Medical Systems, Inc.	$207M	+4.7%	-20.9%	+63.2%	—	+13.3%	+24.0%	+1116.4%
BDXBecton, Dickinson and Company	$55.5B	-1.1%	+0.7%	+51.8%	+3.4pp	+5.0%	+16.9%	+80.2%
MDTMedtronic plc	$99.9B	-9.8%	-18.1%	-2.8%	+3.4pp	-4.2%	-27.7%	+26.5%
BSXBoston Scientific Corporation	$84.1B	-8.5%	-40.3%	-46.0%	—	+6.5%	+31.2%	+155.5%

Compare:CTSO vs NVCR CTSO vs MASI CTSO vs ICUI CTSO vs NVCR vs MASI

About CTSO Dividend Returns

Cytosorbents Corporation (CTSO) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of CTSO over the past year?

Cytosorbents Corporation (CTSO) delivered a return of -30.97% over the past year. Since CTSO does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in CTSO be worth today?

A $10,000 investment in Cytosorbents Corporation one year ago would be worth $6,903 today, representing a loss of $3,097.

Q3Does CTSO pay dividends?

Cytosorbents Corporation (CTSO) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For CTSO, the total return equals the price-only return.

Q4Did CTSO beat the S&P 500?

No, Cytosorbents Corporation (CTSO) underperformed the S&P 500 by 61.35 percentage points over the past year. CTSO delivered a total return of -30.97%, compared to the S&P 500's 30.37%. This means a passive S&P 500 index fund outperformed CTSO by 61.35pp during this period.

Q5What is CTSO's worst drawdown?

Cytosorbents Corporation (CTSO) experienced a maximum drawdown of -57.57% over the past year, declining from its peak on 2025-07-01 to its trough on 2026-04-01. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is CTSO's long-term total return over 10, 20, or 30 years?

Here are Cytosorbents Corporation (CTSO)'s long-term returns with dividends reinvested. Over 10 years, the total return is -86.4% (-18.1% CAGR) — $10,000 would have grown to $1,364. Over 20 years: -99.2% total return (-21.5% CAGR) — $10,000 → $80. Over 30 years: -99.2% total return (-14.9% CAGR) — $10,000 → $80. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was CTSO's best and worst year?

Cytosorbents Corporation's best calendar year was 2014 with a total return of 213.4%. Its worst year was 2007 with a total return of -87.4%. This range shows the volatility investors should expect — the difference between the best and worst year is 300.8 percentage points.